Literature DB >> 7665672

Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.

F Petry1, H A Robinson, V McDonald.   

Abstract

Propagation of Cryptosporidium parvum is problematic because in vitro development of the parasite is poor and animals are only briefly susceptible as neonates. At present oocysts of the parasite are usually procured by passage in neonatal sheep or cattle. In the present study, large numbers of oocysts of C. parvum could be isolated following infection of dexamethasone-treated adult C57BL/6 mice. The amount of immunosuppressive drug and the regimen of administration were critical for successful maintenance of the parasite, however. Routinely, 10 mice (age, 8 to 12 weeks) were injected four times on alternate days with 1.0 mg of dexamethasone, and the last injection was given on the same day as oral inoculation with 10(6) oocysts. By using a simplified procedure for oocyst purification from mouse feces, approximately 10(9) oocysts were obtained. This model is inexpensive and comparatively safe to handle, and the numbers of animals inoculated can be varied to obtain the required number of oocysts. Thus, this murine infection model would be a suitable alternative to the use of neonatal calves or sheep for efficient oocyst propagation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665672      PMCID: PMC228301          DOI: 10.1128/jcm.33.7.1922-1924.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

2.  Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.

Authors:  V McDonald; R Deer; S Uni; M Iseki; G J Bancroft
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man.

Authors:  V McDonald; R M Deer; J M Nina; S Wright; P L Chiodini; K P McAdam
Journal:  Parasite Immunol       Date:  1991-05       Impact factor: 2.280

4.  Experimental Cryptosporidium parvum infections in immunosuppressed adult mice.

Authors:  K R Rasmussen; M C Healey
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus).

Authors:  J A Ernest; B L Blagburn; D S Lindsay; W L Current
Journal:  J Parasitol       Date:  1986-10       Impact factor: 1.276

6.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice.

Authors:  J Heine; H W Moon; D B Woodmansee
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Characterization of cyclophosphamide-rat model of cryptosporidiosis.

Authors:  J E Rehg; M L Hancock; D B Woodmansee
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

8.  Cryptosporidiosis of man and calf: a case report and results of experimental infections in mice and rats.

Authors:  N C Reese; W L Current; J V Ernst; W S Bailey
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

9.  Differentiation between human and animal strains of Cryptosporidium parvum using isoenzyme typing.

Authors:  F M Awad-el-Kariem; H A Robinson; D A Dyson; D Evans; S Wright; M T Fox; V McDonald
Journal:  Parasitology       Date:  1995-02       Impact factor: 3.234

10.  Rat model for human cryptosporidiosis.

Authors:  P Brasseur; D Lemeteil; J J Ballet
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more
  21 in total

1.  A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures.

Authors:  Steven P O'Hara; Jae-Ran Yu; Jim Jung-Ching Lin
Journal:  Parasitol Res       Date:  2004-01-16       Impact factor: 2.289

2.  Cyclospora cayetanensis: first imported infections in Germany.

Authors:  F Petry; J Hofstätter; B K Schulz; G Deitrich; M Jung; P Schirmacher
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

3.  In vitro infection of Cryptosporidium parvum to four different cell lines.

Authors:  J R Yu; S D Choi; Y W Kim
Journal:  Korean J Parasitol       Date:  2000-06       Impact factor: 1.341

4.  Time gap between oocyst shedding and antibody responses in mice infected with Cryptosporidium parvum.

Authors:  Jae-Ran Yu; Soo-Ung Lee
Journal:  Korean J Parasitol       Date:  2007-09       Impact factor: 1.341

5.  Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.

Authors:  Soo-Ung Lee; Mikyo Joung; Taekyoung Nam; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

6.  Pulsed-UV light inactivation of Cryptosporidium parvum.

Authors:  Soo-Ung Lee; Migyo Joung; Dong-Jin Yang; Soon-Ho Park; Sun Huh; Woo-Yoon Park; Jae-Ran Yu
Journal:  Parasitol Res       Date:  2008-02-20       Impact factor: 2.289

7.  In vitro culture of Cryptosporidium muris in a human stomach adenocarcinoma cell line.

Authors:  Min-Ho Choi; Sung-Tae Hong; Jong-Yil Chai; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2004-03       Impact factor: 1.341

8.  Infectivity of Cryptosporidium parvum genotype I in conventionally reared piglets and lambs.

Authors:  M Ebeid; A Mathis; A Pospischil; P Deplazes
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

9.  Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction.

Authors:  I-Sarah Lean; Stuart A C McDonald; Mona Bajaj-Elliott; Richard C G Pollok; Michael J G Farthing; Vincent McDonald
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  CP2 gene as a useful viability marker for Cryptosporidium parvum.

Authors:  Soo-Ung Lee; Migyo Joung; Myoung-Hee Ahn; Sun Huh; Hyunje Song; Woo-Yoon Park; Jae-Ran Yu
Journal:  Parasitol Res       Date:  2007-12-01       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.